A
ANNX
Annexon, Inc.
4.670
-0.200-4.11%After Hours: 4.740 +0.070 +1.50%19:30 09/08 EDT
OPEN/PREV CLOSE4.160/4.140
TODAY RANGE3.960-4.191
VOL1.52M
MARKET CAP752.48M
52 WEEK RANGE2.100-7.18
AVG VOL (3M)3.57M
% TURNOVER0.80%
TURNOVER--
P/E (TTM)-3.4605
% RANGE5.58%
EPS(TTM)-1.1470
P/E(FORWARD)-3.8239
P/B3.725
BVPS1.066
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP710.14M
SHARES OUTSTANDING189.58M
NEXT EARNINGS11/09-11/13
FREE FLOAT178.91M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Dow Jones·09/01 18:44
Annexon Is Maintained at Overweight by JP Morgan
Dow Jones·09/01 18:44
Annexon Price Target Raised to $14.00/Share From $10.00 by JP Morgan
Benzinga·09/01 18:34
JP Morgan Maintains Overweight on Annexon, Raises Price Target to $14
TipRanks·09/01 12:10
Annexon price target raised to $14 from $10 at JPMorgan
TipRanks·08/27 00:14
Annexon Biosciences Bets Big on Pivotal Trial Wins
Simply Wall St·08/21 22:28
Expanded ARCHER II Trial And New Credit Facility Might Change The Case For Investing In Annexon (ANNX)
TipRanks·08/17 15:56
Annexon participates in a conference call with JPMorgan
TipRanks·08/17 10:15
Annexon expands Phase 3 ARCHER II trial
Simply Wall St·08/16 15:19
Annexon (ANNX), Why Is The Market Paying Closer Attention?
Simply Wall St·08/14 07:25
Annexon (ANNX) Is Down 6.1% After Dual Endpoint Shift in ARCHER II Trial - What's Changed
Dow Jones·08/13 13:54
Annexon Raised to Market Perform From Market Underperform by Citizens
Benzinga·08/13 13:48
Citizens Upgrades Annexon to Market Perform
TipRanks·08/13 11:06
Annexon Biosciences (ANNX) Gets a Buy from Wells Fargo
Same Industry
Name/Symbol
Change%
Price